.
MergerLinks Header Logo

Announced

Hillhouse Capital Management to acquire a 7.5% stake in Asymchem for $331m.

Financials

Edit Data
Transaction Value£253m
Consideration TypeCash
Capital Owned-
Capital Bid For8%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Pharmaceuticals

Acquisition

Public

Single Bidder

China

pharmaceutical company

Pending

Private Equity

Minority

Friendly

Synopsis

Edit

Private equity firm Hillhouse Capital Management agreed to acquire a 7.5% stake in Asymchem, a Chinese pharmaceutical company, for $331m. After the deal is complete, Hillhouse will help facilitate deals between Asymchem and the innovative drug firms in which the new investor already invests or will invest in.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US